Krebs Biochemicals & Industries
Krebs Biochemicals & Industries Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Krebs Biochemicals & Industries
Start SIPKrebs Biochemicals & Industries Investment Rating
-
Master Rating:
-
Krebs Biocs.& Inds. has an operating revenue of Rs. 51.42 Cr. on a trailing 12-month basis. An annual revenue de-growth of -13% needs improvement, Pre-tax margin of -47% needs improvement, NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 11 | 9 | 21 | 10 | 18 |
| Operating Expenses Qtr Cr | 16 | 12 | 23 | 17 | 29 |
| Operating Profit Qtr Cr | -5 | -3 | -2 | -7 | -11 |
| Depreciation Qtr Cr | 1 | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 1 | 1 | 1 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -7 | -6 | -4 | -8 | -11 |
Krebs Biochemicals & Industries Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹66.99
- 50 Day
- ₹70.83
- 100 Day
- ₹79.46
- 200 Day
- ₹93.42
- 20 Day
- ₹67.44
- 50 Day
- ₹67.75
- 100 Day
- ₹81.1
- 200 Day
- ₹97.73
Krebs Biochemicals & Industries Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹66.67 |
| Second Resistance | ₹69.29 |
| Third Resistance | ₹70.92 |
| RSI | 34.05 |
| MFI | 35.11 |
| MACD Single Line | -1.33 |
| MACD | -1.78 |
| Support | |
|---|---|
| First Resistance | ₹62.42 |
| Second Resistance | ₹60.79 |
| Third Resistance | ₹58.17 |
Krebs Biochemicals & Industries Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 20,239 | 1,539,783 | 76.08 |
| Week | 13,532 | 1,032,221 | 76.28 |
| 1 Month | 12,621 | 1,185,581 | 93.94 |
| 6 Month | 25,703 | 1,492,042 | 58.05 |
Krebs Biochemicals & Industries Result Highlights
Krebs Biochemicals & Industries Synopsis
NSE-Medical-Generic Drugs
Krebs Biochemicals & belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 52.13 Cr. and Equity Capital is Rs. 21.56 Cr. for the Year ended 31/03/2023. Krebs Biochemicals & Industries Ltd. is a Public Limited Listed company incorporated on 02/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110AP1991PLC103912 and registration number is 103912.| Market Cap | 133 |
| Sales | 51 |
| Shares in Float | 0.58 |
| No of funds | 5 |
| Yield |
| Book Value | -10.12 |
| U/D Vol ratio | 0.4 |
| LTDebt / Equity | |
| Alpha | -0.23 |
| Beta | 0.96 |
Krebs Biochemicals & Industries
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 72.74% | 72.72% | 72.74% | 72.74% |
| Foreign Portfolio Investors | 0.5% | 0.33% | 0.01% | 0.01% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 18.58% | 18.68% | 18.78% | 19.26% |
| Others | 8.18% | 8.27% | 8.47% | 7.99% |
Krebs Biochemicals & Industries Management
| Name | Designation |
|---|---|
| Dr. R T Ravi | Chairman & Non-Exe.Director |
| Mr. Pabitrakumar Kalipada Bhattacharyya | Managing Director |
| Mr. Jitendra Shah | Non Executive Director |
| Mr. G V L Prasad | Independent Director |
| Mr. Raj Kamal Prasad Verma | Independent Director |
| Dr. Tangirala Malati | Independent Director |
| Mr. Satish Khivsara | Independent Director |
| Mr. Avinash Ravi | Non Executive Director |
Krebs Biochemicals & Industries Forecast
Price Estimates
Krebs Biochemicals & Industries Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-24 | Audited Results | |
| 2023-02-03 | Quarterly Results | |
| 2022-11-10 | Quarterly Results | |
| 2022-08-01 | Quarterly Results | |
| 2022-05-23 | Audited Results |
Krebs Biochemicals & Industries FAQs
What is Share Price of Krebs Biochemicals & Industries ?
Krebs Biochemicals & Industries share price is ₹61 As on 28 May, 2023 | 20:37
What is the Market Cap of Krebs Biochemicals & Industries ?
The Market Cap of Krebs Biochemicals & Industries is ₹133 Cr As on 28 May, 2023 | 20:37
What is the P/E ratio of Krebs Biochemicals & Industries ?
The P/E ratio of Krebs Biochemicals & Industries is -5.4 As on 28 May, 2023 | 20:37
What is the PB ratio of Krebs Biochemicals & Industries ?
The PB ratio of Krebs Biochemicals & Industries is -1.3 As on 28 May, 2023 | 20:37